-+ 0.00%
-+ 0.00%
-+ 0.00%

Aclaris Therapeutics Launches Phase 1b Trial of Bispecific Antibody ATI-052 in Atopic Dermatitis

Reuters·01/12/2026 11:55:29

Please log in to view news